Skip to main content
. 2018 Nov 22;5(12):ofy314. doi: 10.1093/ofid/ofy314

Figure 3.

Figure 3.

Changes in incidence of infection by selected multidrug-resistant organisms, patient-centered outcomes, and overall antimicrobial cost after the implementation of postprescription review and feedback.